Artificial Intelligence Aids Discovery of Super Tight-Binding Antibodies
Health & BehaviorUC San Diego scientists developed an artificial intelligence tool that could accelerate the development of new high affinity antibody drugs.
Research
The Latest
A New Phase
Health & BehaviorThe evolution of clinical trials is accelerating, driven by emerging technologies, social imperatives and the next public health crisis.
Four UC San Diego Scientists Elected AAAS Fellows
Science & EnvironmentFour UC San Diego researchers have been elected 2022 AAAS Fellows. Stuart Brody, Massimiliano Di Ventra, Elizabeth Komives and Yunde Zhao are being recognized for their scientifically and socially distinguished achievements by AAAS, publisher of the journal Science.
This Injectable Biomaterial Heals Tissues From the Inside Out
Technology & EngineeringA new biomaterial that can be injected intravenously, reduces inflammation in tissue and promotes cell and tissue repair. The biomaterial was tested and proven effective in treating tissue damage caused by heart attacks in both rodent and large animal models.
Therapeutic Potential of Bizarre ‘Jumbo’ Viruses Tapped for $10M HHMI Emerging Pathogens Project
Science & EnvironmentUC San Diego and its collaborating partners have been awarded $10 million from the Howard Hughes Medical Institute to leverage the biomedical promise of viruses known as bacteriophages as new therapeutic agents in the fight against the rising crisis of antibiotic-resistant bacterial infections.
Supplementation with Amino Acid Serine Eases Neuropathy in Diabetic Mice
Technology & EngineeringWorking with mice, Salk Institute researchers, in collaboration with the University of California San Diego, have identified another factor contributing to diabetes-associated peripheral neuropathy: altered amino acid metabolism.
Trending Stories
A New Way to Predict Cancer’s Spread? Scientists Look at ‘Stickiness’ of Tumor Cells
Health & Behavior
Stay in the Know
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
